SAba Sile
Corporate Officer/Principal bij SPRUCE BIOSCIENCES, INC.
Actieve functies van SAba Sile
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Corporate Officer/Principal | 10-11-2022 | - |
Loopbaan van SAba Sile
Eerdere bekende functies van SAba Sile
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - | - |
Opleiding van SAba Sile
| University of Pittsburgh School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Ierland | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
